Aurélien Amiot

9.1k total citations · 2 hit papers
131 papers, 3.0k citations indexed

About

Aurélien Amiot is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, Aurélien Amiot has authored 131 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Genetics, 57 papers in Surgery and 50 papers in Epidemiology. Recurrent topics in Aurélien Amiot's work include Inflammatory Bowel Disease (63 papers), Microscopic Colitis (43 papers) and Gastric Cancer Management and Outcomes (11 papers). Aurélien Amiot is often cited by papers focused on Inflammatory Bowel Disease (63 papers), Microscopic Colitis (43 papers) and Gastric Cancer Management and Outcomes (11 papers). Aurélien Amiot collaborates with scholars based in France, United States and Italy. Aurélien Amiot's co-authors include Francisca Joly, Yoram Bouhnik, Bernard Messing, Laurent Peyrin‐Biroulet, Yves Panís, Iradj Sobhani, Olivier Corcos, Matthieu Allez, Philippe Sansonetti and Rami Eliakim and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Aurélien Amiot

114 papers receiving 3.0k citations

Hit Papers

European evidence based consensus for endoscopy in inflam... 2013 2026 2017 2021 2013 2022 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. European evidence based consensus for endoscopy in inflammatory bowel disease
    2013 574 citations Aurélien Amiot et al. Journal of Crohn s and Colitis profile →
  2. Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database
    2022 99 citations Léa Hoisnard, Bénédicte Lebrun‐Vignes et al. Scientific Reports profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aurélien Amiot France 25 1.2k 1.2k 1.1k 615 502 131 3.0k
Alfredo Papa Italy 36 1.9k 1.6× 1.4k 1.2× 1.4k 1.3× 340 0.6× 493 1.0× 161 3.9k
Mariabeatrice Principi Italy 30 638 0.5× 1.1k 0.9× 666 0.6× 580 0.9× 318 0.6× 125 2.3k
Yasushi Iwao Japan 35 1.7k 1.4× 938 0.8× 1.5k 1.4× 472 0.8× 748 1.5× 162 4.3k
Pieter Hindryckx Belgium 28 2.1k 1.7× 1.1k 1.0× 1.5k 1.4× 349 0.6× 658 1.3× 88 3.5k
Kim L. Isaacs United States 29 2.3k 1.9× 1.3k 1.1× 1.5k 1.5× 394 0.6× 521 1.0× 95 3.9k
Alan G. Fraser New Zealand 28 1.1k 0.9× 1.0k 0.9× 842 0.8× 386 0.6× 332 0.7× 69 2.7k
Nagamu Inoue Japan 32 1.7k 1.4× 751 0.6× 1.2k 1.1× 255 0.4× 811 1.6× 91 3.5k
Hendrik M. van Dullemen Netherlands 30 1.5k 1.3× 1.6k 1.4× 1.1k 1.1× 261 0.4× 994 2.0× 79 4.2k
Davide Giuseppe Ribaldone Italy 29 914 0.8× 788 0.7× 1.1k 1.0× 445 0.7× 488 1.0× 182 2.6k
Richard J. Farrell United States 27 1.1k 1.0× 1.2k 1.1× 1.3k 1.2× 783 1.3× 196 0.4× 72 3.6k

Countries citing papers authored by Aurélien Amiot

Since Specialization
Citations

This map shows the geographic impact of Aurélien Amiot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurélien Amiot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurélien Amiot more than expected).

Fields of papers citing papers by Aurélien Amiot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurélien Amiot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurélien Amiot. The network helps show where Aurélien Amiot may publish in the future.

Co-authorship network of co-authors of Aurélien Amiot

This figure shows the co-authorship network connecting the top 25 collaborators of Aurélien Amiot. A scholar is included among the top collaborators of Aurélien Amiot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurélien Amiot. Aurélien Amiot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meyer, Antoine, Franck Carbonnel, Christina C. Dahm, et al.. (2025). Fruits, Vegetables, Legumes, and Potatoes and Risk of Crohn's Disease and Ulcerative Colitis. The American Journal of Gastroenterology. 121(3). 733–744.
2.
Reenaers, Cathérine, Maria Nachury, David Laharie, et al.. (2024). DOP23 The role of histology for the prediction of clinical relapse in Crohn’s Disease: A substudy of the STORI cohort. Journal of Crohn s and Colitis. 18(Supplement_1). i117–i117. 1 indexed citations
3.
Reenaers, Cathérine, Maria Nachury, David Laharie, et al.. (2024). Impact of Histological Remission for Predicting Clinical Relapse in Crohn’s Disease: A Post Hoc Analysis of the Prospective STORI Cohort. Journal of Crohn s and Colitis. 19(4). 1 indexed citations
4.
5.
Lama, Yago González, Ioannis E. Κoutroubakis, Ioannis Drygiannakis, et al.. (2024). P663 Efficacy of jak inhibitors in inflammatory bowel disease patients with extraintestinal manifestations– Retrospective study. Journal of Crohn s and Colitis. 18(Supplement_1). i1251–i1253.
6.
7.
Wils, Pauline, Nadia Arab, Aurélien Amiot, et al.. (2024). Infliximab is an effective option in patients with ulcerative colitis previously exposed to full subcutaneous anti-TNF agent: Results from a real-world multicenter study. Digestive and Liver Disease. 56(8). 1312–1318. 2 indexed citations
8.
Steyerberg, Ewout W., María José Casanova, Guillaume Bouguen, et al.. (2023). Discontinuation of Anti-Tumour Necrosis Factor Therapy in Patients with Perianal Fistulizing Crohn’s Disease: Individual Participant Data Meta-Analysis of 309 Patients from 12 Studies. Journal of Crohn s and Colitis. 18(1). 134–143. 2 indexed citations
9.
Becq, Aymeric, Alexis Laurent, Quentin de Roux, et al.. (2023). Long-Term Results of Endoscopic Metal Stenting for Biliary Anastomotic Stricture after Liver Transplantation. Journal of Clinical Medicine. 12(4). 1453–1453. 3 indexed citations
10.
Buisson, Anthony, Maria Nachury, Romain Altwegg, et al.. (2022). Real‐world comparison of effectiveness between tofacitinib and vedolizumab in patients with ulcerative colitis exposed to at least one anti‐TNF agent. Alimentary Pharmacology & Therapeutics. 57(6). 676–688. 15 indexed citations
11.
Carbonnel, Franck, Émilie Routier, Thierry Lazure, et al.. (2022). Severe colitis in patients with melanoma treated with BRAF/MEK inhibitors. Alimentary Pharmacology & Therapeutics. 57(7). 792–799. 4 indexed citations
12.
Hoisnard, Léa, Bénédicte Lebrun‐Vignes, Sébastien Maury, et al.. (2022). Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database. Scientific Reports. 12(1). 7140–7140. 99 indexed citations breakdown →
13.
Uzzan, Mathieu, David Laharie, Carmen Stefănescu, et al.. (2021). Tofacitinib as salvage therapy for 55 patients hospitalised with refractory severe ulcerative colitis: A GETAID cohort. Alimentary Pharmacology & Therapeutics. 54(3). 312–319. 36 indexed citations
14.
Becq, Aymeric, Iradj Sobhani, Thomas Lambin, et al.. (2021). Endoscopic training during fellowship: A nationwide French study. Clinics and Research in Hepatology and Gastroenterology. 46(2). 101837–101837.
15.
Gagnière, Charlotte, Anne Bourrier, Philippe Seksik, et al.. (2018). Risk of serious infection in healthcare workers with inflammatory bowel disease: a case‐control study of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID). Alimentary Pharmacology & Therapeutics. 48(7). 713–722. 7 indexed citations
16.
Pouillon, Lieven, Guillaume Pineton de Chambrun, Lucine Vuitton, et al.. (2018). Dose de-escalation to adalimumab 40 mg every three weeks in patients with inflammatory bowel disease—A multicenter, retrospective, observational study. Digestive and Liver Disease. 51(2). 236–241. 12 indexed citations
17.
Martineau, Chloé, Bernard Flourié, Pauline Wils, et al.. (2017). Efficacy and safety of golimumab in Crohn's disease: a French national retrospective study. Alimentary Pharmacology & Therapeutics. 46(11-12). 1077–1084. 23 indexed citations
18.
Genova, Pietro, Aurélien Amiot, Cécile Charpy, et al.. (2017). Robotic Versus Laparoscopic Gastric Resection for Primary Gastrointestinal Stromal Tumors >5 cm: A Size-Matched and Location-Matched Comparison. Default journal. 27. 65–71. 3 indexed citations
19.
Nahon, Stéphane, Aurélien Amiot, Stanislas Chaussade, et al.. (2016). Rate and Predictors of Mucosal Healing in Ulcerative Colitis Treated with Thiopurines: Results of a Multicentric Cohort Study. Digestive Diseases and Sciences. 62(2). 473–480. 7 indexed citations
20.
Amiot, Aurélien, Maya Tchikviladzé, Francisca Joly, et al.. (2009). Frequency of Mitochondrial Defects in Patients With Chronic Intestinal Pseudo-Obstruction. Gastroenterology. 137(1). 101–109. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alfredo Papa Breakdown of academic impact, for papers by Mariabeatrice Principi Breakdown of academic impact, for papers by Yasushi Iwao Breakdown of academic impact, for papers by Pieter Hindryckx Breakdown of academic impact, for papers by Kim L. Isaacs Breakdown of academic impact, for papers by Alan G. Fraser Breakdown of academic impact, for papers by Nagamu Inoue Breakdown of academic impact, for papers by Hendrik M. van Dullemen Breakdown of academic impact, for papers by Davide Giuseppe Ribaldone Breakdown of academic impact, for papers by Richard J. Farrell
Rankless by CCL
2026